Bullous pemphigoid (BP) in an infant complicated by tuberculous meningoencephalitis

International Journal of Dermatology

Volumn 46, Issue 9, 2007, Pages 964-966

  Nanda, Arti ^a,b   Nanda, Mousmee ^a   Dvorak, Richard ^a   Al sabah, Humoud ^a   Alsaleh, Qasem A ^a  

^a AL SABAH HOSPITAL   (Kuwait)

^b NONE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; COMPLEMENT COMPONENT C3; DAPSONE; ETHAMBUTOL; IMMUNOGLOBULIN G; ISONIAZID; PREDNISOLONE; RIFAMPICIN;

ACID FAST BACTERIUM; ARTICLE; BLISTER; BLOOD CELL COUNT; BULLOUS PEMPHIGOID; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; COMPLEMENT DEPOSITION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; LEUKOCYTOSIS; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PRESCHOOL CHILD; REMISSION; SKIN BIOPSY; TUBERCULOUS MENINGITIS; VESICULAR RASH;

FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MYCOBACTERIUM; PEMPHIGOID, BULLOUS; PREDNISOLONE; SKIN; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

EID: 34548522970     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03194.x     Document Type: Article

References (16)

1. Fisler RE, Saeb M, Liang MG, et al. Childhood bullous pemphigoid: A clinicopathologic study and review of the literature. Am J Dermatopathol 2003; 25: 183-189.
2. Amos B, Deng JS, Flynn K, et al. Bullous pemphigoid in infancy: Case report and literature review. Pediatr Dermatol 1998; 15: 108-111.
3. Oranje AP, Vuzevski VD, van Joost T, et al. Bullous pemphigoid in children: Report of three cases with special emphasis on therapy. Int J Dermatol 1991; 30: 339-342.
4. Wisuthsarewong W, Viravan S, Kulthanan K. Bullous pemphigoid in an infant: A case report and literature review. J Med Assoc Thai 1997; 80: 270-274.
5. Cunha PR, Thomazeski PV, Hipolito E, et al. Bullous pemphigoid in a 2-month-old infant. Int J Dermatol 1998; 37: 935-938.
6. Trueb RM, Didierjean L, Fellas A, et al. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigen. J Am Acad Dermatol 1999; 40: 338-344.
7. Chimanovitch I, Hamm H, Georgi M, et al. Bullous pemphigoid of childhood: Autoantibodies target the same epitope within the NC 16A domain of BP 180 as autoantibodies in bullous pemphigoid of adulthood. Arch Dermatol 2000; 136: 527-532.
8. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001; 44: 348-350.
9. Petronius D, Bergman R. Bullous pemphigoid in two young infants. Pediatr Dermatol 2002; 19: 119-121.
10. Kuenzli S, Grimaitre M, Krischer J, et al. Childhood bullous pemphigoid: report of a case with life-threatening course during homeopathy treatment. Pediatr Dermatol 2004; 21: 160-163.
11. Voltan E, Maeda JY, Muniz Silva MA, et al. Childhood bullous pemphigoid: report of three cases. J Dermatol 2005; 32: 387-392.
12. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003; 139: 1051-1059.
13. Ruetter A, Luger TA. Efficacy and safety of intravenous immunoglobulin for immune-mediated skin diseases: Current view. Am J Clin Dermatol 2004; 5: 153-160.
14. Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulins in children with Steven-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 2003; 112: 1430-1436.
15. Al-Mayouf SM, Laxer RM, Schneider R, et al. Intravenous immunoglobulin therapy for juvenile dermatomyositis: Efficacy and safety. J Rheumatol 2000; 27: 2498-2503.
16. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Auitoimmunity 2005; 38: 235-245.